Company / Current Assets
Apogee Therapeutics, Inc. Current Assets History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$529.7M
FY2024
5-year range
$152.1M / $529.7M
FY2022-FY2024
Trend
+33.0%
vs FY2023
Sector context
#110 of 213
Health Care
What the data says
At $530M, Apogee Therapeutics, Inc.'s current assets ranks #110 of 213 in the Health Care sector. Improved from $152M to $530M over the past 2 years.
Based on SEC 10-K filings.
$530M in FY2024.
Improved from $152M to $530M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 213 in Health CareTop 52% of 213This company $529.7M Sector average $2.5B
▼
-79.0% below sector average
Key checks
Key Insights
- In FY2024, current assets increased 33.0% year-over-year.
- Ranks #110 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $529.7M | +33.0% |
| FY2023 | $398.4M | +162.0% |
| FY2022 | $152.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026